A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said a visiting professor at Rutgers University.
The executive director of Patients Come First - New Jersey (PCF-NJ) said that government price setting in health care will negatively impact “access to research and cures.”
A national health policy analyst said New Jersey patients served by a hospital participating in the federal 340b drug program should be concerned the drug savings aren’t being passed along to them.
Insurance companies “denying coverage” of the prescription drugs she needed to deal with chronic migraines is one reason Jeannette Hoffman wanted to become the executive director for the newly-formed group, Patients Come First-New Jersey.
A new “patient advocacy” organization, Patients Come First, today launched in New Jersey, announcing longtime New Jersey communications professional Jeannette Hoffman as the group’s executive director.